{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-003483","form_type":"8-K","ticker":null,"cik":"0001872356","company_name":"Molekule Group, Inc.","filed_at":"2023-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.294584+00:00","generated_at":"2026-06-20T16:11:47.599692+00:00","sec_items":["1.01","2.03","2.01","5.02","5.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"AeroClean completes all-stock merger with Molekule; combined company to trade as MKUL","bullets":["AeroClean stockholders own ~50.5%, Molekule stockholders ~49.5% of combined company; ticker changes to MKUL.","Pro forma combined revenue ~$48M in FY2022, ~$13M in Q4; installed base >350,000 units.","Assumes ~$34.4M of Molekule debt from SVB; co-borrower; must maintain $2M unrestricted cash.","Brad Feld appointed to board; Jonathan Harris becomes Chief Commercial Officer.","Recent product milestones: Pūrgo FDA clearance for SARS-CoV-2; new PECO-HEPA Tri-Power Filter."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-003483","json":"https://secwatch.observer/filing/0001104659-23-003483.json","markdown":"https://secwatch.observer/filing/0001104659-23-003483.md","text":"https://secwatch.observer/filing/0001104659-23-003483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/tm233138d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:11:47.599692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68e2ae736afba7ff6053f823a206733b1158fff9","claim":"Molekule Group, Inc. amended lease obligation with Trinity.","evidence_excerpt":"On January 12, 2023, AeroClean executed a joinder to the master lease agreement with Trinity.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"lease obligation"},{"label":"Counterparty","value":"Trinity"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"f1391deb101c0f16c269ed899e315f2f5564f7d5","claim":"Molekule Group, Inc. amended credit facility with Silicon Valley Bank.","evidence_excerpt":"On January 12, 2023, AeroClean executed a joinder agreement, became a co-borrower under each Loan Agreement and granted SVB a first priority lien on substantially all of AeroClean’s assets, other than certain customary excluded assets.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Counterparty","value":"Silicon Valley Bank"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"58bd059217","claim":"Brad Feld was appointed as director at Molekule Group, Inc..","evidence_excerpt":"the Company Board increased the size of the Company Board from seven members to eight members and filled the resulting vacancy on the Company Board by appointing Brad Feld (who was designated by Molekule) as a director of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"6ae2739a00","claim":"Ritankar Pal was appointed as Chief Operating Officer at Molekule Group, Inc..","evidence_excerpt":"the Company Board appointed Jonathan Harris as Chief Marketing & Product Development Officer of the Company and Ritankar “Ronti” Pal as Chief Operating Officer of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"8f87450c4d","claim":"Jonathan Harris changed role as Chief Commercial Officer at Molekule Group, Inc..","evidence_excerpt":"the Company amended Mr. Harris's employment agreement to change his title from Chief Marketing & Product Development Officer to Chief Commercial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"},{"claim_id":"11e0cfdb1cce0b2c20c2dbde6e4f90bf8205bbf5","claim":"Molekule Group, Inc.: Amended and restated Bylaws to change company name and add a six-month lockup provision for former Molekule stockholders (effective 2023-01-12).","evidence_excerpt":"On January 12, 2023, the Company Board amended and restated the Company’s Bylaws (the “ Second Amended and Restated Bylaws ”) to reflect the change of the Company’s name to “Molekule Group, Inc.” and include a six-month lockup provision that prohibits the former Molekule stockholders from transferring their Merger Consideration during the six-month period following the Closing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-01-12"}],"fact_type":"governance_change"},{"claim_id":"151de4719f85ffa22507853d3e358ab7685b8d5f","claim":"Molekule Group, Inc.: Amended certificate of incorporation to change company name to 'Molekule Group, Inc.' and add officer exculpation provision (effective 2023-01-12).","evidence_excerpt":"On January 12, 2023, in connection with the consummation of the Merger, and subsequent thereto, AeroClean amended its certificate of incorporation to change the name of the Company to “Molekule Group, Inc.” and include a provision exculpating the officers of the Company from liability for breaches of fiduciary duty to the extent permitted by Delaware law (the “ Amended and Restated Certificate of Incorporation ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-01-12"}],"fact_type":"governance_change"},{"claim_id":"c31a629ab07efff448964b279139a6b5acbfbcee","claim":"Molekule Group, Inc. completed an acquisition involving Molekule, Inc. for 14,907,210 shares of Company common stock, plus warrants and RSUs, resulting in Molekule stockholders holding 49.5% of outstanding shares (closed 2023-01-12).","evidence_excerpt":"of such shares of Molekule Common Stock were entitled to receive, by virtue of the Merger and upon the terms and subject to the conditions set forth in the Merger Agreement, 14,907,210 fully paid and nonassessable shares of Company common stock, par value $0.01 per share (the “ Company Common Stock ”), that resulted in the Molekule stockholders in the aggregate,","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.95,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Molekule, Inc."},{"label":"Consideration","value":"14,907,210 shares of Company common stock, plus warrants and RSUs, resulting in Molekule stockholders holding 49.5% of outstanding shares"},{"label":"Closing","value":"2023-01-12"}],"fact_type":"ma_transaction"},{"claim_id":"135217e84f19208f9380318c6ad22d52c5e8d928","claim":"Molekule Group, Inc. entered into Stockholders Agreement with certain stockholders of AeroClean and certain stockholders of Molekule (effective 2023-01-12).","evidence_excerpt":"On January 12, 2023, AeroClean entered into a stockholders agreement with certain stockholders of AeroClean and certain stockholders of Molekule (the “ Stockholders Agreement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"certain stockholders of AeroClean and certain stockholders of Molekule"},{"label":"Effective","value":"2023-01-12"}],"fact_type":"material_agreement"},{"claim_id":"e98d34e0c9e89f801340342bf4e5b063a9112784","claim":"Molekule Group, Inc. entered into Amended and Restated Registration Rights Agreement with certain stockholders of AeroClean and Molekule (effective 2023-01-12).","evidence_excerpt":"On January 12, 2023, AeroClean and certain stockholders of AeroClean and Molekule entered into an Amended and Restated Registration Rights Agreement (the “ Amended and Restated Registration Rights Agreement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872356/000110465923003483/0001104659-23-003483-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"certain stockholders of AeroClean and Molekule"},{"label":"Effective","value":"2023-01-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}